glp-1 studies near me How should receptor agonists be managed in the perioperative period? Real-World Evidence for GLP-1 Receptor

Unraveling the microbial puzzle: exploring the intricate role of gut microbiota in endometriosis pathogenesis

Tirzepatide's Recent Market Entry and Dual-Peptide Innovation Tirzepatide introduced a new mechanism in 2022 by simultaneously activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptorsa dual-peptide approach not previously available in weight loss therapy

Van Hoeck V, Bols PEJ, Binelli M, Leroy JL

Glucagon-like peptide-1 (GLP-1) has emerged as a therapeutic agent for metabolic diseases such as obesity, NAFLD, and atherosclerosis, largely by improving lipid, glucose, and cholesterol metabolism [15]